BRAY AND SLAUGHTER LIMITED
Company number 00286527 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: BRAY AND SLAUGHTER LIMITED
1. Financial Health Score: B+
Explanation: The patient exhibits robust underlying vitality with a strong heartbeat (cash position) and consistent muscle growth (retained earnings). However, there are symptoms of circulatory congestion (ballooning trade debtors) that require monitoring. The high blood pressure (current liabilities) is typical for the construction sector but necessitates ongoing management to ensure it doesn't lead to acute distress.
2. Key Vital Signs
- Pulse (Liquidity): Strong but slightly strained. The current ratio sits at 1.18 (£4.83m current assets / £4.09m current liabilities). The company can comfortably cover its short-term debts, but the margin is modest for an industry prone to sudden cash flow shocks.
- Blood Pressure (Leverage): Moderately elevated. Total liabilities represent roughly 70% of total assets. While this is a healthy improvement from historical highs (such as 2019 when liabilities exceeded net assets), it still indicates a reliance on external funding and creditor support.
- Respiration (Cash Flow): Deep and steady. Cash at bank stands at a healthy £1.41 million, up from £1.33 million in 2025 and significantly recovered from the £0.8m dip in 2020. The company is breathing comfortably and not gasping for immediate liquidity.
- Muscle Mass (Net Assets): Steadily building. Shareholders' funds have grown to £1.74 million, up from £1.59 million, continuing a five-year trend of strengthening equity. The business is building a healthy financial constitution.
3. Diagnosis
Primary Diagnosis: Chronic Circulatory Congestion due to Sector-Specific Strain.
The patient is fundamentally healthy and generating good profits (£148,882 retained this year), but is suffering from a mild case of "fluid retention" in the form of trade debtors. Amounts owed by customers have more than doubled from £1.55 million to £3.27 million in a single year. While this corresponds with an increase in trade creditors (up to £1.58 million from £1.13 million)—suggesting the company is successfully passing some of this payment pressure onto its own suppliers—it indicates that cash is tied up in the working capital cycle.
In the construction industry, it is common to see this "arterial plaque" build up as contracts grow larger and payment terms stretch. The company has also increased its workforce from 21 to 26 employees, indicating expansion, which naturally demands more working capital. The underlying tissue (the freehold property valued at £950,000) provides a solid foundation, and the director's loan account is negligible (£13,592 outstanding), meaning management is not draining the company's lifeblood for personal use.
4. Prognosis
Outlook: Positive, provided lifestyle adjustments are made.
The financial outlook is highly favorable if the company can maintain its profit generation. The transition from a precarious position in 2019 (when net assets were only £701k and liabilities outweighed assets) to today's robust equity position shows excellent resilience. However, if trade debtors continue to swell without corresponding cash collection, the company risks a "cardiac event"—where cash runs dry despite being nominally profitable, potentially triggering defaults on its own creditor obligations.
5. Recommendations
To maintain optimal financial wellness and prevent future complications, I recommend the following regimen:
- Cardiovascular Exercise (Improve Cash Conversion): Implement stricter credit control procedures. The debtor book is disproportionately large. Chasing outstanding invoices more aggressively will accelerate cash flow, lower the current ratio strain, and reduce the risk of bad debt "clots."
- Dietary Monitoring (Manage Creditor Terms): Continue to negotiate favourable terms with suppliers (trade creditors) to balance the extended terms being given to clients, but avoid stretching them to the point of critical supplier relationships rupturing.
- Blood Tests (Regular Contract Audits): Given the rise in "payments on account" (up to £802k from £325k), ensure that contract valuations and billing are strictly aligned with work completed to prevent over-valuation or under-recovery on commercial builds.
- Vitamin Supplements (Maintain Cash Buffers): Retain a portion of the healthy profits to build an even larger cash reserve. With a growing workforce and larger contracts, an unexpected shock could require immediate cash intervention.